C4 Therapeutics, Inc.

CCCCNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$35.9M

▲ 1.0% YoY

Net Income

-$105.0M

▲ 0.3% YoY

EPS

$-1.27

▲ 16.4% YoY

Cash

$74.6M

▲ 34.4% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.